You are here

  • Home
  • Archive
  • Volume 77, Issue 3
  • A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Extended report
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Zhang F, Bae S, Bass D, et al
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Annals of the Rheumatic Diseases 2018;77:355-363.